The health industries in Nigeria and other African countries are threatened by the influx of fake or substandard drugs.
This is according to a new study by researchers at Bahir Dar University in Ethiopia which revealed that up to 22.6%-over one-fifth-of medicines in Africa are either fake or substandard.
This, the study noted poses a significant risk to the continent’s fragile public health system.
The study, published on the United States National Library of Medicine website, stated that over a third (34.6%) of medicines on the continent are unregistered, with antibiotics accounting for 44% of these unregistered drugs.
In the study, researchers reviewed 27 studies and discovered that out of 7,508 medicine samples analyzed, 1,639 failed at least one quality test, confirming them to be substandard or falsified.
Read Also: NGO Extends Medical Outreach To Six Underserved Communities In Ogun
The study attributed the prevalence of fake and substandard medicines in Africa to poor market regulatory oversight, free trade zones, inadequate registration, high demand, and substandard importation practices.
The report states, “The overall estimated prevalence of substandard/falsified medicines in Africa was 22.6% (1718/7592). The average prevalence of unregistered medicines was 34.6% (108/312). Antibiotics, antimalarial, and antihypertensive medicines accounted for 44.6% (712/1596), 15.6% (530/3530), 16.3% (249/1530), and 16.3% (249/1530), respectively. Approximately 60.7% (91/150) were antihelmintic and antiprotozoal medicines. Poor market regulatory permission, Free trade zones, poor registration, high demand, and poor importation standards contribute to the prevalence of these problems.”
According to the study, Kenya had the highest percentage of fake and substandard unregistered antibiotics, and antimalarial drugs at 17% followed by Malawi at 10.7%.
The study aligns with a 2017 World Health Organisation (WHO) study, which estimated that one in 10 medical products in developing countries are substandard or falsified. According to the report, 42% of substandard and falsified medicine reports come from Africa, 21% from the Americas, and 21% from Europe